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Hematopoietic stem cell differentiation involves the
silencing of self-renewal genes and induction of a
specific transcriptional program. Identification of
multiple covalent cytosine modifications raises the
question of how these derivatized bases influence
stem cell commitment. Using a replicative primary
human hematopoietic stem/progenitor cell differ-
entiation system, we demonstrate dynamic changes
of 5-hydroxymethylcytosine (5-hmC) during stem cell
commitment and differentiation to the erythroid line-
age. Genomic loci that maintain or gain 5-hmC
density throughout erythroid differentiation contain
binding sites for erythroid transcription factors and
several factors not previously recognized as
erythroid-specific factors. The functional importance
of 5-hmC was demonstrated by impaired erythroid
differentiation, with augmentation of myeloid poten-
tial, and disrupted 5-hmC patterning in leukemia
patient-derived CD34+ stem/early progenitor cells
with TETmethylcytosine dioxygenase 2 (TET2) muta-
tions. Thus, chemical conjugation and affinity purifi-
cation of 5-hmC-enriched sequences followed by
sequencing serve as resources for deciphering func-
tional implications for gene expression during stem
cell commitment and differentiation along a partic-
ular lineage.CINTRODUCTION
The propensity to generate multilineage hematopoietic cells
from nascent uncommitted blood stem cells defines the
complexity of the bone marrow system and serves as a para-
digm for stem cell differentiation. Accumulated evidence has
demonstrated the ability of a single hematopoietic cell to lose
multilineage potential and commit to a specific blood cell type,
a complex process involving extrinsic and intrinsic signals heavi-
ly influenced by the stem cell microenvironment (Ogawa, 1993;
Smith et al., 1991; Spradling et al., 2001). Lineage commitment
by stem cells is characterized by initiating a specific trans-
criptional program while simultaneously silencing large numbers
of genes that maintain the self-renewal characteristics of the
stem cell compartment.
Although accumulated data underscore the importance of
extrinsic factors in lineage commitment, very little is known
about the epigenetic changes that accompany lineage commit-
ment and differentiation. Ten-Eleven-Translocation (TET) family
members are dioxygenases that catalyze the conversion of
5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC)
and other covalent cytosine modifications, which have the
potential to provide additional complexity to overall gene regula-
tion (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). Contro-
versy exists as to whether Tet1 is required for pluripotency, with
some studies showing that Tet1 knockdown leads to sponta-
neous differentiation of mouse embryonic stem cells (ESCs)
(Ito et al., 2010) and others failing to demonstrate compromised
self-renewal capacity (Dawlaty et al., 2011; Koh et al., 2011; Wil-
liams et al., 2011). Genome-wide mapping of 5-hmC in mouseell Reports 6, 231–244, January 16, 2014 ª2014 The Authors 231
Figure 1. Dynamic Changes in 5-hmC and 5-mC Levels during Erythroid Differentiation
(A) Photomicrographs of hematoxylin and benzidine-stained cells cytospun onto slides on the days indicated. Changes in cellular morphology as well as
acquisition of HB (brown) during the differentiation program are seen in the micrographs.
(B and C) Total 5-hmC (B) and 5-mC (C) content in cells at days 0, 3, 7, 10, 13, and 17 during in vitro erythroid differentiation, measured by LC-MS. The average
(± SD) of two independent biological replicates obtained from two independent donor CD34+ cells is shown. Repeated measures ANOVAwas used to determine
statistical significance.
(D) Total 5-hmC content in the erythroid fractions isolated from baboon bone marrow. ‘‘R6’’ is the CD117+ CD36 bRBC fraction of cells, which form
granulocytic, mixed, and large BFUe colonies in methylcellulose. This population contains both early progenitors and later nonerythroid progenitors. ‘‘R7’’ is
the CD117+CD36+ fraction, which forms CFUe and late BFUe in methylcellulose (10%–20% erythroid colony-forming cells). ‘‘R8’’ is the CD117 CD36+
(legend continued on next page)
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ESCs demonstrated an association with active chromatin marks
as well as the enrichment of 5-hmC at transcriptional start sites
and within enhancer regions, suggesting that 5-hmC plays a
role in transcriptional regulation (Pastor et al., 2011; Stroud
et al., 2011; Williams et al., 2011; Wu et al., 2011; Wu and Zhang,
2011b). Many studies have demonstrated a role for 5-hmC and
the Tet enzymes in DNA methylation reprogramming in the
mammalian zygote (Ficz et al., 2011; Gu et al., 2011; Iqbal
et al., 2011; Wossidlo et al., 2011). However, whether 5-hmC
functions as an intermediate in active or passive demethylation
pathways, confers its own epigenetic function, or both, is not
defined. Furthermore, many studies have examined 5-mC
versus 5-hmC in cells in a single differentiation state and,
therefore, have not been able to test how 5-hmC distribution
changes during the course of differentiation. Until recently,
most studies employed approaches that cannot distinguish 5-
mC from 5-hmC, making it difficult to map dynamic changes
precisely in the epigenetic landscape during stem cell commit-
ment to a particular lineage. The current study provides compre-
hensive analysis of 5-hmC changes in a dynamic fashion during
human stem/early progenitor cell commitment to the erythroid
lineage and during subsequent differentiation, providing a
valuable resource for understanding the relationship between
epigenetic modifications and transcription factor (TF) binding
as well as the generation of molecular hypotheses regarding
stem cell commitment.
RESULTS
Global Levels of 5-hmC Change Dramatically during
Erythropoiesis
To decipher the precise role(s) of 5-hmC in stem cell commit-
ment, we chose a well-defined erythroid commitment and
differentiation model (Kang et al., 2008; Tamez et al., 2009; Ud-
din et al., 2004), in which primary human hematopoietic stem/
early progenitor cells differentiate during 17 days of in vitro
culture in a replicative, synchronous, and orderly progression
through all of the known erythroid intermediates (Figures 1A,
S1A, and S1B). The day 0 starting cell population was highly
enriched for stem/early progenitor cells (74.8% ± 6.8%
CD34+/CD90+) and was devoid of cells expressing myeloid or
lymphoid markers (Figure S1A; Table S1). Our culture conditions
were permissive for erythroid-lineage commitment by day 3 as
confirmed by expression of EPOR, GATA1, and HBB, all highly
representative genes for erythroid cells (Figure S1C). These
features were critical to our ability to utilize this model to assess
the dynamic changes in 5-hmC marks and gene expression thatbRBC fraction, which does not form colonies in methylcellulose. ‘‘RBC+’’ is the
using Miltenyi Biotec columns with the baboon-specific red blood cell (RBC) ant
blood cell (WBC) was used as a control. Data are represented as the mean of tw
(E) Total 5-mC content in the erythroid fractions isolated from baboon bone marr
biological replicates ± SD.
(F) qRT-PCR for TET1 (white bars), TET2 (gray bars), and TET3 (black bars) expre
differentiation. The average (± SD) of two independent biological replicates is sh
(G) Representative western blot showing expression of TET2 protein in nuclear ex
histone H3, the loading control.
See also Figure S1 and Table S1.
Caccompany hematopoietic stem cell commitment to definitive
erythropoiesis.
First, we used mass spectrometry to determine the global
levels of 5-hmC (Figures 1B and S1D) and 5-mC (Figure 1C)
at differentiation stages that correspond to defined erythroid
intermediates, occurring at days 0, 3, 7, 10, 13, and 17 (stem/
early progenitors, BFU-E, basophilic, polychromatic, orthochro-
matic, and reticulocytes, respectively). Total 5-hmC levels
increased during stem/early progenitor cell commitment to the
erythroid lineage, followed by a dramatic decrease throughout
subsequent differentiation (Figures 1B and S1A–S1D). The effect
was observed consistently in four independent biological repli-
cates. In contrast, global 5-mC content decreased modestly
throughout stem/early progenitor cell commitment and sub-
sequent differentiation (Figure 1C), consistent with previous
observations within murine erythropoiesis (Bock et al., 2012;
Shearstone et al., 2011). We further confirmed these findings in
populations of erythroid progenitors isolated directly from bone
marrows of baboons (Figures 1D and 1E). TET2 mRNA levels,
measured by real-time PCR and confirmed by RNA sequencing
(RNA-seq), were greatest in the day 0 CD34+ stem/early progen-
itors and exhibited a dramatic decrease thereafter, although
maintained detectable levels until day 7 (Figure 1F). Expression
levels of TET1 and TET3 were negligible at every time point (Fig-
ure 1F). The levels of TET2 protein were highest on day 3, the
time period when CD34+ cells commitment to the erythroid line-
age occurs (Figure 1G).
Locus-Specific Distribution of 5-hmC Undergoes
Dynamic Changes during Erythropoiesis
Using chemical conjugation and affinity purification of 5-hmC-
enriched sequences followed by next-generation sequencing
(hMe-Seal) (Song et al., 2011), we determined the sites of
dynamic changes in 5-hmC density across the entire genome
on days 0, 3, 7, and 10, which allowed us to focus on the steps
of stem/early progenitor cell commitment and subsequent differ-
entiation into erythroblasts. We performed hMe-Seal on three
independent samples derived from unique human donors and
found that there was a high degree of correlation among them,
with r2 values R 0.96 (Figure S2A). Simultaneously with these
measurements, we performed RNA-seq (Table S2), on two of
these individuals (the same donors whose samples yielded
biological replicates #1 and #2 from the hMe-Seal data), enabling
us to correlate 5-hmC dynamics with gene expression changes.
Again, we found a high degree of correlation on days 0 and 10
between the biological replicates, with r2 values R0.8
(Figure S2B).fraction of erythroid precursors that do not form colonies and that were purified
ibody (BD Biosciences). All numbers were normalized to RBC+ values. White
o independent biological replicates ± SD.
ow, as described in (D). Data are represented as the mean of two independent
ssion normalized to 18S, at days 0, 3, 7, 10, 13, and 17 during in vitro erythroid
own.
tracts from cells at days 0, 3, 7, and 10. The blot was stripped and reprobed for
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We first quantified the total number of 5-hmC peaks that were
gained or lost in the intervals days 0–3, days 3–7, and days 7–10,
with a minimum fold change of two (Figure S2C). Strikingly, we
observed much more loss of 5-hmC peaks across all intervals,
with the maximum loss occurring between days 0 and 3 (Fig-
ure S2C, white bars). 5-hmC peak gain occurred as erythroid
commitment and differentiation began, peaking between days
3 and 7 (Figure S2C, black bars). We performed a similar analysis
with gain and loss of gene expression and found that in parallel
with the loss of 5-hmC peaks, initial stem/early progenitor cell
commitment is associated most with a loss in gene expression
(Figure S2D, white bars). Transcriptional upregulation was
most pronounced as erythroid commitment and differentiation
occurred between days 0 and 3 as well as from days 3 to 7
(Figure S2D, black bars). We observe the expression of many
genes decreasing as differentiation proceeds, with the augmen-
tation in gene expression of only a relatively small number of
lineage-specific genes. This observation is in agreement with
existing ideas of how stem cells display promiscuous gene
expression of multiple lineages (Krause, 2002).
Next, we correlated the association between gains/losses
of 5-hmC with particular gene expression patterns. Most
notably, the greatest numbers of 5-hmC peaks were lost in
genes whose expression levels fall immediately at day 3, many
of which correspond to genes required for stem cell function,
followed by genes whose expression levels decrease continu-
ously throughout differentiation (Figure S2E). We also examined
the patterns of gene expression as a function of the pattern of
gain/loss in 5-hmC peaks. Loss of gene expression most often
was associated with an initial loss of hydroxymethylation at
day 3, and upregulation of gene expression was most often
seen with initial gain in 5-hmC peaks (Figure S2F).
Given the complexity of the dynamics seen in both 5-hmC
and gene expression patterns, we focused next on classifying
the genomic location of 5-hmC peaks that were gained or lost
in genes whose expression consistently increased (Figure S2G)
or decreased (Figure S2H) over the four time points. Consistency
in expression was defined at a change of 2-fold between at least
two time points, with no change in any other time interval. The
level of 2-fold was chosen because it accurately reflected
the known dynamics for key genes classically recognized in
erythropoiesis. We observed enrichment of 5-hmC peaks in
gene bodies for genes with increased expression compared to
genes whose expression decreased.
Peaks with consistently decreased expression generally lost
5-hmC peaks in their gene bodies, with predominant loss in
introns, and exhibited rare gain in 5-hmC (Figure S2G). In
contrast, peaks consistently upregulated across all time points
showed much less loss in 5-hmC density (Figure S2H).Figure 2. Dynamic Changes of 5-hmC Peaks and RNA-Seq in Regions
(A) RNA-seq (red) and hMe-Seal (green) tracks in the CD34 gene.
(B) Pie charts depict results of bisulfite sequencing (outer rows) and TAB-seq (inn
gene on day 0 (top) and day 10 (bottom). For bisulfite sequencing, the percentage
for TAB-seq, the percentage of unmodified cytosines is shown in white, of 5-mC i
compare 5-hmC percentages at days 0 and 10.
(C–F) RNA-seq (red) and hMe-Seal (green) tracks in regions surrounding CD38 (C
See also Figures S2 and S3.
CNext, to determine if there was a functional association of
5-hmC peaks at specific regions with gene expression, we
overlaid data from hMe-Seal and RNA-seq for genes critical for
stem and progenitor function (Figure 2; Table S2), including
CD34 (Figure 2A), CD38 (Figure 2C), CD45 (Figure 2D), CD90
(Figure 2E), and CD133 (Figure 2F). 5-hmC peaks paralleled
the expression of the genes, with 5-hmC peaks appearing
throughout the gene body at day 0, but disappearing quickly
as stem/early progenitor cell commitment to the erythroid line-
age occurred and differentiation proceeded. To determine the
fate of the 5-hmC bases that disappear with differentiation, we
employed single-base resolution using the Tet-assisted bisulfite
sequencing (TAB-seq) method to distinguish unmodified cyto-
sine, 5-mC, and 5-hmC. We chose two representative regions
near or within CD34 and observed that 5-hmC is present at
high levels on day 0 but that these particular CpG residues
were replaced by 5-mC by day 10 (Figure 2B). This is represen-
tative of 5-hmC loss with DNA replication in a gene that loses
expression with differentiation. We picked the region 4 kb
upstream of CD34 to measure cytosine modifications across
all time points and found a significant increase in 5-hmC levels
on day 3, followed by a highly significant decrease on day 7 (Fig-
ure S3A), indicating that the site underwent conversion to un-
modified cytosine and immediate remethylation.
In contrast, genes that are induced during erythroid differ-
entiation showed a more variable and dynamic pattern in
5-hmC distribution, as shown by the genes within the hemoglo-
bin (HB) cluster, which expresses the b, d, g, and ε chains (Fig-
ure 3A). Different regions throughout the promoters and gene
bodies gained and/or lost 5-hmC, indicating a level of dynamic
change heretofore unappreciated in studies of cells at one
particular stage of differentiation. BCL11A, a molecular regulator
involved in HB switching (Lettre et al., 2008; Sankaran et al.,
2008; Uda et al., 2008), binds to an intergenic region 50 from
the transcription start site of HBD (HB d) as well as to the
HPFH (hereditary persistence of fetal HB) and locus control
(LCR) regions. We observed an increase in 5-hmC density at
these regions as the cells underwent erythroid differentiation,
which further implicates the importance of 5-hmC in the control
of gene expression within the HB gene cluster (Figure 3A). To
determine the dynamics of 5-hmC changes within HBB (Fig-
ure 3B), we used single-base resolution TAB-seq to examine
the changes in cytosine modification for two 5-hmC peaks with
opposite changes during differentiation, one peak that increased
as differentiation proceeded, and one that was lost with differ-
entiation. For the peak that gains 5-hmC density with differ-
entiation (Figure 3C, left panel), we observed that this region
was highly methylated when the gene was not expressed but
gained extensive hydroxymethylation with gene expressionSurrounding Stem and Progenitor Cell Genes
er rows) showing quantitation of modified cytosines over regions of the CD34
of unprotected cytosines is shown in white and of protected cytosines in black;
n black, and of 5-hmC in green. p values were calculated by using the c2 test to
), CD45 (D), CD90 (E), and CD133 (F).
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Figure 4. Functional Significance of 5-hmC
Gains
(A) Total number of gained 5-hmC peaks between
days 0 and 3 (days 0–3, white), 3 and 7 (days 3–7,
hatched), and 7 and 10 (days 7–10, striped) with
respect to relative position to annotated gene
elements.
(B) Relative number of 5-hmC peaks from (A) nor-
malized to the base pair lengths of each element.
(C) Comparison of the normalized 5-hmC reads
surrounding the TSS, indicated by a vertical
dotted line, ±1,000 bp for all known annotated
genes at day 0 (left) versus day 10 (right), plotted
by the Metaseq suite (Dale, 2013).
(D) Percentage of the overlap among publicly
available GATA1, GATA2, and KLF1 ChIP-seq
data (Fujiwara et al., 2009; Kang et al., 2012;
Tallack et al., 2010) and 5-hmC gained peaks over
days 0–3 (white), 3–7 (hatched), and 7–10 (striped)
time points with significance (p % 105).
See also Figure S4.and differentiation. This gain represents regions where 5-hmC
density confers an epigenetic function unto itself because
density increases even with DNA replication. This suggests
that the base confers an important cell function because
5-hmC gain requires the action of two enzymes, DNMT and
TET, in order to accumulate with DNA replication. In contrast,
the region that lost 5-hmC density with differentiation (Figure 3C,
right panel) showed decrease in 5-hmC density from 14% (day 0)
to 0% at day 10, with substantial loss of 5-mC, indicating exten-
sive demethylation resulting in mostly unmodified cytosines at
this region. Additional examples from the overlay of data from
RNA-seq and hMe-Seal for genes that represent various func-
tional categories and play an important role during erythropoi-
esis are summarized in Figure S3B.
Loci that Gain 5-hmC during Differentiation Correspond
to Gene Regulatory Regions
Given these significant shifts in 5-hmC peak locations, we next
chose to focus on regions that gained 5-hmC density throughout
differentiation. We reasoned that because cells are activelyFigure 3. Dynamic Changes of 5-hmC Peaks and RNA-Seq in Regions Surrounding the HB Ge
(A) RNA-seq (red) and hMe-Seal (green) tracks in the region surrounding the HB cluster. Black bars indica
(BCL11A binding site), and LCR.
(B) Results in (A) magnified to show the HBB gene.
(C) Pie charts depict results of bisulfite sequencing (outer rows) and TAB-seq (inner rows) showing quantitatio
0 (top) and day 10 (bottom). For bisulfite sequencing, the percentage of unprotected cytosines is shown in whi
the percentage of unmodified cytosines is shown in white, of 5-mC in black, and of 5-hmC in green. p value
5-hmC percentages at days 0 and 10.
See also Figures S2 and S3.
Cell Reports 6, 231–244dividing in the first 10 days of culture,
much of the loss in hydroxymethylation
that we observe could be accounted for
by passive demethylation due to DNA
replication (Williams and Wang, 2012).
Furthermore, we hypothesized that the
DNA loci at which the 5-hmC base wasmost likely to confer important epigenetic function would be
found in regions that demonstrated maintenance and, more so,
gain of 5-hmC because both DNA methyltransferase and TET2
enzyme functions would be required at those positions to main-
tain or gain 5-hmC marks in this replicative system.
Therefore, we analyzed the DNA loci that gained 5-hmC
density across any two time points and correlated the known
gene annotations at those sites (Figure 4A). We found that gain
in 5-hmC was most often found in gene bodies and TF binding
sites. However, when we normalized the gene annotations to
their respective base pair lengths, we found that only CpG
islands failed to gain 5-hmC in proportion to their length, in
contrast to all other genomic regions (Figure 4B). Furthermore,
gains in 5-hmC were observed mainly in the early stages of
lineage commitment and erythroid differentiation (up to day 7)
and were not seen from days 7 to 10 (Figure 4B). When we
analyzed the 5-hmC binding profile near transcription start sites
of known annotated genes, we observed redistribution of 5-hmC
density as erythroid differentiation progressed from days 0 to 10
(Figure 4C).ne Cluster
te known regulatory regions: HPFH, BCL11A-BS
n of modified cytosines over regions ofHBB on day
te and of protected cytosines in black; for TAB-seq,
s were calculated by using the c2 test to compare
, January 16, 2014 ª2014 The Authors 237
Table 1. Transcription Factor Binding Sites within Regions that Gain 5-hmC during Erythroid Differentiation
Transcription Factor Binding Site Sequencea
p Values Transcripts per Cell
Days 0–3 Days 3–7 Days 7–10 Day 0 Day 3 Day 7 Day 10
GATA2 BBCTTATCTS 1 3 10369 1 3 101,742 1 3 1069 98.8 73.8 28.4 14.5
GATA1 SAGATAAGRV 1 3 10368 1 3 101,652 1 3 1068 9.2 100.2 127.7 126.0
KLF1 NWGGGTGTGGCY 1 3 1036 1 3 10244 1 3 1019 5.7 80.4 267.1 381.2
NF1 CYTGGCABNSSTGCCA 1 3 105 1 3 10154 1 3 1010 6.7 2.7 3.0 2.3
STAT5A RTTTCTNAGAAA 1 3 1036 1 3 1052 < 1 3 105 56.3 60.1 46.9 6.8
STAT1 NATTTCCNGGAAAT 1 3 1029 1 3 1039 < 1 3 105 12.6 4.8 5.5 7.1
NF-E2 GATGACTCAGCA 1 3 1016 1 3 1018 < 1 3 105 91.2 117.4 178.3 492.2
HIF1A TACGTGCV 1 3 1015 1 3 1015 < 1 3 105 57.9 9.8 8.9 16.7
EGR1 TCCGCCCACGCA 1 3 1014 1 3 106 < 1 3 105 71.9 12.4 30.6 63.0
MYB GGCVGTTR 1 3 1010 1 3 1025 < 1 3 105 136.1 91.8 70.9 21.6
STAT3 CTTCCGGGAA 1 3 109 1 3 1011 < 1 3 105 42.5 26.7 19.3 10.0
Myc VCCACGTG 1 3 107 1 3 1035 < 1 3 105 27.7 57.0 71.3 29.1
Max RCCACGTGGYYN 1 3 107 1 3 1033 < 1 3 105 36.7 21.4 19.1 32.0
USF1 SGTCACGTGR 1 3 106 1 3 1040 < 1 3 105 34.9 21.5 20.8 25.2
ATF3 SGGTCACGTGAC 1 3 106 1 3 1027 < 1 3 105 40.7 0.38 0.87 12.6
CEBP ATTGCGCAAC 1 3 10342 < 1 3 105 < 1 3 105 6.4 11.7 18.5 82.7
DRTGTTGCAA 1 3 10147 < 1 3 105 < 1 3 105
c-Jun VTGACTCATC 1 3 10112 < 1 3 105 < 1 3 105 515.4 1.2 0.86 3.8
RUNX1 AAACCACARM 1 3 1097 < 1 3 105 < 1 3 105 41.2 26.4 12.7 6.7
RUNX2 NWAACCACADNN 1 3 1075 < 1 3 105 < 1 3 105 8.2 0.6 0.2 0.2
GCTGTGGTTW 1 3 1068 < 1 3 105 < 1 3 105
ATF4 GATTGCATCA 1 3 1066 < 1 3 105 < 1 3 105 176.2 208.5 196.9 286.78
SPI1 AGAGGAAGTG 1 3 1023 < 1 3 105 < 1 3 105 53.5 68.1 12.2 4.0
ERG ACAGGAAGTG 1 3 1011 < 1 3 105 < 1 3 105 34.5 4.9 0.63 0.17
STAT6 TTCCKNAGAA 1 3 107 < 1 3 105 < 1 3 105 54.6 17 17.4 16.3
Sp1 GGCCCCGCCCCC < 1 3 105 1 3 1013 < 1 3 105 21.6 11.7 15.0 29.2
ZNF711 AGGCCTAG < 1 3 105 1 3 109 < 1 3 105 32.4 5.2 2.8 1.5
The list is limited to motifs with an enrichment of p > 1 3 105 on the basis of HOMER software ChIP-seq analysis and a putative transcription factor
mRNA expression of more than five transcripts per cell based on whole-transcriptome sequencing at days 0, 3, 7, or 10 of erythroid differentiation.
aNucleic acid nomenclature. A, adenine; T, thymine; G, guanine; C, cytosine; R, guanine or adenine; Y, thymine or cytosine; M, adenine or cytosine; K,
guanine or thymine; S, guanine or cytosine; W, adenine or thymine; H, adenine, cytosine, or thymine; B, guanine, thymine, or cytosine; V, guanine,
cytosine, or adenine; D guanine, thymine, or adenine; N, any nucleic acid.To understand the functional significance of the DNA loci
that maintained or gained 5-hmC during erythropoiesis, we
analyzed the sequence motifs present in these regions, specif-
ically focusing on the presence of known TF binding site motifs
and correlating with their expression (Table 1). The highest
number of hits for significantly enriched motifs included motifs
for three TFs known to be critical in erythropoiesis: GATA1,
GATA2, and KLF1. The expression of GATA1 and KLF1 is
dramatically increased during erythroid differentiation, whereas
GATA2 levels are greatly reduced during the same time period
(Table 1).
To test for experimental evidence of TF binding to the
5-hmC-enriched sites, we extracted the publicly available data
from studies that have measured binding of these particular
TFs during erythropoiesis by chromatin immunoprecipitation
sequencing (ChIP-seq) (Fujiwara et al., 2009; Kang et al.,
2012; Tallack et al., 2010; Xu et al., 2012) and analyzed overlap238 Cell Reports 6, 231–244, January 16, 2014 ª2014 The Authorswith the regions that gained 5-hmC density during erythroid dif-
ferentiation (Figure 4D). We found that between 15% and 34%
of the ChIP-seq peaks corresponded to DNA loci that gained
5-hmC density, indicating an overlap of TF binding sites with
5-hmC enrichment at a significant level (p < 105). We found
the presence of a CpG dinucleotide in close proximity to the
TF binding sites of GATA1, GATA2, and KLF1. When we
analyzed the distance from the TF binding motif to each CpG
within the 5-hmC-enriched sequences, we observed co-occur-
rence between the TF binding motif and the CpG contained
within it, suggesting colocalization of 5-hmC with TF binding
(Figures S4A–S4C). We also examined the co-occurrence of
5-hmC binding with TF binding during erythroid differentiation
at the HB gene cluster. Every peak corresponding to the binding
of GATA1, GATA2, and/or KLF1 measured by ChIP-seq coin-
cided with a region with 5-hmC gain, suggesting that 5-hmC
marks enhancer/TF binding sites needed for stem/early
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Figure 5. Overlap of Histone Marks as well as DNA Methylation
Dynamics with 5-hmC Peaks that Were Gained between Days 0 and
3, 3 and 7, and 7 and 10
(A) Overlap of the distribution of particular histone modifications (deposited by
Xu et al., 2012) and gain of 5-hmC density throughout erythroid differentiation.
Scores were calculated as the ratio of actual overlap relative to a normal
distribution generated by random permutations (yellow, high normalized
enrichment; green, medium normalized enrichment; and blue, low normalized
enrichment). All normalized enrichment scores except H3K9me3 reached
significance of at least 105. z, levels of significance for H3K9me3 versus
5-hmC enrichment were days 0–3 (p = 0.066), 3–7 (p < 105), and 7–10
(p = 0.075).
(B) Percentage of overlap between 5-hmC-specific peaks identified during
erythroid differentiation and modified cytosines identified using the HELP
assay (Yu et al., 2013).progenitor cell differentiation (Figure S4D). There was also
enrichment of GATA1 and GATA2 in the region surrounding
the LCR, which is a distal regulatory element that controls
gene expression within the HBB cluster (Bauer et al., 2012)
(Figure S4D). Overlap of 5-hmC gains with GATA1 binding sites
was enriched both for sites at which GATA1 functions as a
transcriptional activator as well as at those at which it represses
transcription (Figures S4E and S4F). The enrichment of 5-hmC
at these sites was maintained within the HB cluster region in
baboon erythroid progenitor cells, again indicating species
conservation and likely preserved function (Figures S4G
and S4H).
Next, we analyzed whether the genomic regions that gained
5-hmC during erythropoiesis correlated with the positions ofCmodified histones of known function as measured by Xu
and colleagues in an independent human ex vivo erythroid
differentiation system (Xu et al., 2012). There were higher
levels of normalized overlap between loci that gained 5-hmC
and activating histone marks, such as H3K9 acetylation,
H3K4me1, and H3K4me3, as erythroid differentiation proceeded
(Figure 5A).
We recently published an analysis of how modified cytosine
bases change throughout erythroid differentiation using the
HELP assay, which does not distinguish between 5-mC and
5-hmC (Yu et al., 2013). By comparing our hMe-Seal data
to these HELP data, we were able to define common peaks.
We found that as differentiation progressed, the percentage of
5-hmC peaks that overlapped with the ‘‘peaks’’ obtained from
the HELP assay diminished, suggesting that as erythroid cells
develop, an increasing fraction of modified cytosines are due
to actual 5-mC bases (Figure 5B).
To test the functional significance of reduced 5-hmC density
on hematopoietic differentiation, we contrasted the potential of
CD34+ cells derived from normal healthy donors to primary
chronic myelomonocytic leukemia (CMML) samples that were
either TET2 wild-type (TET2WT) or mutant (TET2MUT) to differen-
tiate down the myeloid and erythroid lineages. We chose CMML
as a model because patients commonly demonstrate anemia
and myeloproliferation, and 30%–50% of cases carry TET2 mu-
tations (Abdel-Wahab et al., 2009; Jankowska et al., 2009; Tefferi
et al., 2009; Yamazaki et al., 2012). CD34+ cells were selected
from these patient samples and cultured under conditions to
promote erythroid and myeloid differentiation for 14 days. Anal-
ysis on day 14 showed that CD34+ cells obtained from patients
with TET2MUT CMML were unable to differentiate properly into
erythroid cells but were fully capable of generating myeloid cells
(Figures 6A and 6B). CD34+ cells from patients with TET2WT
CMML were mixed in their hematopoietic differentiation capac-
ity: two of the samples were able to differentiate equally well
into myeloid and erythroid cells, whereas a third sample differen-
tiated preferentially down the myeloid lineage (Figures 6A and
6B). Of note, the three TET2WT samples were all IDH1/IDH2WT
in genotype. Because TET2 catalyzes the conversion of 5-mC
to 5-hmC, we measured the total 5-hmC and 5-mC content of
the erythroid cells at day 10. Patients with TET2MUT had signifi-
cantly lower 5-hmC than both nonmalignant and CMML TET2WT
samples (Figure 6C) as well as higher 5-mC levels (Figure 6D).
In vitro erythroid differentiation was performed usingmurine cells
with germline Tet2 knockout alleles (Moran-Crusio et al., 2011),
and mature erythroid (CD71+/Ter119+) cells had significantly
lower 5-hmC and increased 5-mC content in comparison with
Tet2wt mice (Figures S5A and S5B).
In order to interrogate the genome-wide distribution of 5-hmC
with TET2 deficiency, we compared the 5-hmC patterns as
measured by hMe-Seal in one TET2MUT CMML sample at day
10 of erythroid differentiation to our established data from
healthy donors. We observed 36% less coverage of the genome
by 5-hmC in the TET2MUT CMML sample (Figure 6E, inset),
consistent with our data obtained from mass spectrometry
(Figure 6C). Notably, there was significant redistribution of the
5-hmC density, with loss of 5-hmC peaks from intronic regions
and gain in intergenic regions (Figure 6E). One striking exampleell Reports 6, 231–244, January 16, 2014 ª2014 The Authors 239
Figure 6. TET2 Mutations and 5-hmC Deficiency Impede Erythroid Differentiation and Enhance Myeloid Development
(A) Bone marrow-derived CD34+ cells from healthy nonmalignant TET2WT donors (top panel) or from patients with CMML with TET2WT (middle panel) or TET2mut
(bottom panel) were differentiated down the erythroid (left) or myeloid lineage (right). Differentiation was determined by FACS at day 14. Erythroid differentiation
was determined by expression of Glycophorin A and CD71, and myeloid differentiation by expression of CD15 and CD33. Photomicrographs of cytospins
prepared at each time point are shown to the right of each FACS plot.
(B) Differential differentiation potential was quantified by calculating amyeloid:erythroid (M:E) ratio for each sample.Myeloid expressionwasdefinedby theCD15+
andCD15+CD33+populations, and erythroid differentiationwasdefined using theGlycophorin A+CD71+population. Samples fromhealthy nonmalignant TET2wt
cells are shown in orange, those from patients with TET2wt CMML are shown in white, and those from patients with TET2mut CMML are shown in blue.
(C) Total 5-hmC levels measured at day 10 of in vitro erythroid differentiation, as determined by LC/MS. Data are represented as mean ± SEM.
(D) Total 5-mC levels measured in these same samples, as determined by LC/MS. Data are represented as mean ± SEM.
(E) Overlap in 5-hmC reads in nonmalignant CD34+ cells (orange) versus CD34+ cells derived from a patient with TET2-mutated CMML (blue) at day 10 after
in vitro erythroid differentiation. Inset is a Venn diagram showing the number of base pairs covered by 5-hmC peaks in the respective samples.
(F) RNA-seq (top track, gray) and hMe-Seal tracks (for nonmalignant CD34+ cells, middle track, orange; versus patient with TET2-mutated CMML, bottom track,
blue) in the region surrounding GATA1.
See also Figure S5.of this redistribution is seen at the GATA1 locus, where there
is gain of 5-hmC density in the CMML TET2MUT sample, which
is not seen with normal erythroid differentiation (Figure 6F). It is240 Cell Reports 6, 231–244, January 16, 2014 ª2014 The Authorsimportant to note from this example that the TET2 mutation
does not simply result in loss of 5-hmC density but allows for
redistribution of the base, with focal regional gains.
DISCUSSION
To date, 5-hmC has been studied in a variety of contexts,
including the early zygote and in ESCs and their differentiated
counterparts. The majority of the work in ESCs has shown that
5-hmC is an essential component of stem cell function, with
potential roles in transcriptional regulation (Dawlaty et al.,
2011; Ficz et al., 2011; Gu et al., 2011; Iqbal et al., 2011; Ito
et al., 2010; Koh et al., 2011; Pastor et al., 2011; Stroud et al.,
2011; Williams et al., 2011; Wossidlo et al., 2011; Wu et al.,
2011; Wu and Zhang, 2011a, 2011b; Xu et al., 2011). These
studies left open the question whether this DNA modification
is prevalent during adult stem cell commitment and whether
5-hmC played any role within the differentiated cells themselves.
Our work studies 5-hmC in human stem/early progenitor
CD34+ cells as well as in several defined erythroid develop-
mental stages, allowing us to follow the progression of 5-hmC
dynamically from stem/early progenitor cell commitment
throughout cellular differentiation along a single lineage. By
combining 5-hmC profiling with RNA-seq, wewere able to corre-
late alterations in 5-hmC with gene expression. As has been
observed in previous studies (Ficz et al., 2011; Gu et al., 2011;
Iqbal et al., 2011; Pastor et al., 2011; Stroud et al., 2011; Williams
et al., 2011;Wossidlo et al., 2011;Wu et al., 2011;Wu and Zhang,
2011a, 2011b), expression of genes important in stem cell func-
tion is highly hydroxymethylated when expressed, like CD34.
Using TAB-seq, we demonstrated that transcriptional repression
of CD34 was associated with loss of 5-hmC and gain of 5-mC at
particular CpG residues. Like prior work in mouse ESCs (Bock
et al., 2012; Shearstone et al., 2011), we also observe that genes
important for stem cell function are downregulated by DNA
methylation in differentiating cells, accompanied by a large
overall decrease in the amount of 5-hmC in the latter stages of
differentiation.
Notably, we observe that particular DNA loci gain 5-hmC as
differentiation proceeds. Because cells undergo DNA replication
in our in vitro system, this argues that there is an active process
in place to maintain and, in some cases, augment 5-hmC levels
at these loci, implying that this epigenetic base has function at
those sites. We observed a strong correlation between these
regions and TF binding, supporting that 5-hmC is a positive regu-
lator of TF function and implicating several TFs not previously
known to be important in hematopoiesis. Taken together, these
results suggest that 5-hmC acts both as an intermediate in
demethylation to reactivate genes silenced in the primitive
stem/early progenitor cell state as well as an activating mark
that is distributed widely across expressed genes conferring
stem-like function as well as at particular TF binding motifs.
Prior studies in ESCs have shown that 5-hmC is associated
with the activating histone marks H3K4me1, H3K4me3, and
H3K27ac (Pastor et al., 2011; Stroud et al., 2011; Williams
et al., 2011). Similar to this work, we also observe a strong cor-
relation between the presence of the activating histone marks
H3K4me1–H3K4me3, H3K9ac, and H3K27ac, and regions that
gain 5-hmC, suggesting that key mechanisms of gene transcrip-
tion are conserved during embryonic as well as adult cell devel-
opment. Thus, we predict that gain of 5-hmC in these locations
acts in conjunction with activating histone marks to openCcondensed chromatin and allow TF binding and facilitate the
function of these proteins.
Our genome-wide hMe-Seal and RNA-seq data will serve as
valuable resources that will generate hypotheses for investiga-
tors interested in deciphering the molecular mechanisms that
drive stem/early progenitor cell commitment with particular rele-
vance to those studying hematopoiesis. The utility of this model
is in identifying genomic regions that preserve or gain 5-hmC
density as stem/early progenitor cells differentiate down partic-
ular lineages, and this will be a powerful strategy to decipher
DNA loci that control gene expression. Along with well-known
erythroid-specific TFs GATA1, GATA2, and KLF1, our analyses
identified TFs that have been reported previously but not studied
extensively as principal erythroid differentiation factors,
including USF1, ATF3, and ATF4. USF1 (upstream TF 1), a
basic-helix-loop-helix (bHLH) TF that binds to E box motifs
(50-CACGTG-30), has been shown to work sequentially and
cooperatively with other bHLH proteins such as Myc during
erythroid differentiation (Anantharaman et al., 2011). USF1 has
also been shown to recruit SET1 and NURF to chromatin insu-
lator sequences to retain active chromatin structure in erythro-
cytes (Li et al., 2011b). ATF3/ATF4 encode members of the
cAMP-responsive element binding (CREB) protein family of
TFs. ATF3, normally involved in cellular stress response, has
been shown to play a role in platelet-derived growth factor
(PDGF)-mediated signaling of erythropoietin activation (Xue
et al., 2012). ATF4 has been shown to play a role in definitive
erythropoiesis, with Atf4 knockout mice failing to proliferate
and contribute to overall erythropoiesis (Masuoka and Townes,
2002). The data presented can be regarded as a starting point
in the identification of previously uncharacterized factors that
may be involved in erythroid-lineage differentiation andwill serve
as a unique resource for further experimentation and analysis of
epigenetic modification in lineage-specific differentiation.
The functional importance of 5-hmC for hematopoietic differ-
entiation is demonstrated by the preferential myeloid differentia-
tion potential of TET2-deficient cells, both in human CMML
samples as well as in Tet2-deficient mice, as has been observed
previously (Ko et al., 2011; Li et al., 2011a; Moran-Crusio et al.,
2011; Quivoron et al., 2011). TET2 deficiency results in overall
lower 5-hmC levels and skewing of 5-hmC distribution, not sim-
ply loss of 5-hmC density. This inherent block in differentiation
implies that particular therapeutic strategies may need to differ
between TET2WT and TET2MUT myeloid diseases, especially if
the treatments rely on induction of normal cell differentiation.
Our work establishes hydroxymethylation as an important epige-
netic signal that promotes commitment and differentiation of
adult hematopoietic stem/early progenitor cells.
Our work further emphasizes that to interpret data correctly
regarding DNA methylation status, it is essential to employ tech-
niques that can distinguish among the known covalent cytosine
modifications (Madzo et al., 2013). If techniques such as sodium
bisulfite sequencing are used, then complete interpretation
as to whether a particular cytosine residue is methylated or
hydroxymethylated is not possible. Such techniques may give
the impression that there is no change in methylation status
but will miss dramatic shifts in modification. Pairing these
techniques with a technique such as TAB-seq, which canell Reports 6, 231–244, January 16, 2014 ª2014 The Authors 241
differentiate 5-hmC from 5-mC, can help address the functional
role that each individual base plays in transcriptional regulation
and expression. The ability to distinguish among the covalent
cytosine modifications will be essential to appreciate the
dynamic nature of their distribution throughout differentiation.
EXPERIMENTAL PROCEDURES
Detailed procedures are provided in the Supplemental Experimental
Procedures.
Hematopoietic Stem/Progenitor Cell Culture and Erythroid
Differentiation
All human material was collected under studies approved by institutional
review boards. Human CD34+ cells were purified from mobilized peripheral
blood and cultured according to previously published methods (Tamez
et al., 2009; Uddin et al., 2004). CD34+ cells from CMML patient samples
were selected using the EasySep CD34 Positive Selection Kit (STEMCELL
Technologies), and cells were placed into one of two culture conditions: the es-
tablished erythroid differentiation conditions as detailed in the aforementioned
publications, or myeloid conditions (i.e., IMDMwith 15% FCS and 15% human
serum, 10 ng/ml SCF, 20 ng/ml IL-3, 100 ng/ml FLT3L, and 10 ng/ml G-CSF).
Cultures were analyzed after 7 and 14 days by Wright-Giemsa staining in the
case of myeloid cells, and hematoxylin-benzidine staining for erythroid pro-
genitors to allow visualization of hemoglobinization. Mouse stem and progen-
itor cells were cultured according to previously established protocols (Dev
et al., 2010). All Tet2/ mice were housed in a pathogen-free barrier facility
at the University of Chicago, maintained under International Animal Care and
Use Committee guidelines and an approved protocol.
Analysis of Global DNA Methylation and Hydroxymethylation
DNA hydrolysis was performed, and 5-mC and 5-hmC detected using a Zor-
bax XDB-C18 2.13 50mmcolumn (1.8 mmparticle size) attached to an Agilent
1200 Series liquid chromatography machine in tandem with the Agilent 6410
Triple Quad Mass Spectrometer.
5-hmC-Labeling Reaction
Sonicated genomic DNA was labeled with chemically modified uridine diphos-
phoglucose glucose (UDP-6-N3-Glu) with standard methods (Song et al.,
2011). The DNA samples were then purified by MinElute Reaction Cleanup
Kit (Qiagen) and quantified using a Nanodrop UV spectroscope (Thermo Fisher
Scientific).
5-hmC-Sequencing Data Mapping and Analysis
The 5-hmC reads for days 0, 3, 7, and 10 were mapped to the reference
genome hg19 using BWA. Peak calling for each sample was performed using
MACS.
RNA-Seq Data Mapping and Analysis
The RNA-seq reads for days 0, 3, 7, and 10 were mapped to the reference
genome hg19 using TopHat. Gene expression analysis was performed with
Cufflinks.
Bisulfite and TAB-Seq
Identification of 5-mC or 5-hmC with single-base resolution was performed as
described (Yu et al., 2012).
Identification of TF Binding Site Motifs
All 5-hmC-peaks that gained in expression were extracted to perform a TF
binding site analysis using HOMER with default parameters for motif
identification.
5-hmC Overlap with Known TF and Histone Binding
To analyze the overlap between DNA regions that gain 5-hmC with known his-
tonemodifications, we used the data set generated by Stuart Orkin’s group (Xu
et al., 2012). We overlapped the 5-hmC gained peaks with histone modifica-242 Cell Reports 6, 231–244, January 16, 2014 ª2014 The Authorstions and compared them by permuting the 5-hmC peaks 1,000 times. From
the actual versus randomized overlap, we calculated the normalized enrich-
ment with the pybedtools randomstats function.
ACCESSION NUMBERS
The data corresponding to the input, 5-hmC-enriched, and RNA-seq tracks
were deposited into the NCBI Gene Expression Omnibus under accession
number GSE40243.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
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